Physician-industry Conflict Of Interest In Multiple Sclerosis Treatment

If you're one of the nearly half a million Americans living with multiple sclerosis (MS) - a slowly disabling disease of the central nervous system - you are likely dependent on disease-modifying drugs to prevent symptoms such as vision problems, balance issues and weakness. Often, these treatments have been developed through pharmaceutical industry-sponsored clinical trials (ISCT) in collaboration with academic or private practice physicians who care for MS patients. But what do patients know, or want to know, about their physician's financial relationship with the pharmaceutical company sponsoring such research? read more

Read the whole article on

More from